Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis
ITROMICRFDTA
1 other identifier
observational
70
1 country
1
Brief Summary
This study aimed to evaluate the upstream events of Th17/Treg imbalance in CRS and their immune regulatory factors. Then the investigators aimed to explore the regulatory role of miRNA on DC-Th axis and its dysfunction in the pathogenesis of CRS, in order to determine the miRNA expression profile in CRS and clarify the role of miRNA in the pathogenesis of CRS by regulating the DC-Th axis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 15, 2014
CompletedFirst Posted
Study publicly available on registry
December 25, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 25, 2014
December 1, 2014
1 year
December 15, 2014
December 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abnormal microRNA in the Chronic Rhinosinusitis are found by gene chip and qPCR.
6 to 24 months post procedure
Study Arms (4)
control
Patients with only nasal septum deviation
CRS sNP
Chronic Rhinosinusitis patients without nasal polyps
atopic CRS wNP
Chronic Rhinosinusitis patients with allergic constitution and nasal polyps
non-atopic CRS wNP
Chronic Rhinosinusitis patients with nasal polyps but not allergic constitution
Interventions
DCs are transfected by the miRNA mimics or inhibitors after they are separated from peripheral blood mononuclear cells in CRS patients
Eligibility Criteria
Participants will be selected from the department of endoscopic sinus surgery in the First Affiliated Hospital of Chongqing Medical University.
You may qualify if:
- CRS diagnosis is accord with diagnostic criteria of The European nasal sinusitis, nasal polyps guidelines (EPOS 2012) .
- Selected subjects are stopped using systemic or topical corticosteroids in one month before experiment.
- All the patients have sinus CT and nasal endoscopy and allergen Skin Prick Test in preoperative.
- Aged from 18 to 75 years old.
- Woman or man.
You may not qualify if:
- Choanal polyp, fungal nasal sinusitis, cystic fibrosis.
- Acute upper respiratory tract infection and other diseases associated with the body.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Related Publications (1)
Ma ZX, Tan X, Shen Y, Ke X, Yang YC, He XB, Wang ZH, Dai YB, Hong SL, Hu GH. MicroRNA expression profile of mature dendritic cell in chronic rhinosinusitis. Inflamm Res. 2015 Nov;64(11):885-93. doi: 10.1007/s00011-015-0870-5. Epub 2015 Sep 4.
PMID: 26337346DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guo-hua Hu HG Guo-hua Hu, MD
First Affiliated Hospital of Chongqing Medical University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis
Study Record Dates
First Submitted
December 15, 2014
First Posted
December 25, 2014
Study Start
July 1, 2014
Primary Completion
July 1, 2015
Study Completion
December 1, 2016
Last Updated
December 25, 2014
Record last verified: 2014-12